Literature DB >> 32771281

Health Policy and Kidney Care in the United States: Core Curriculum 2020.

Mallika L Mendu1, Daniel E Weiner2.   

Abstract

Kidney care in the United States is highly regulated, reflecting the dominance of Medicare as the primary payer for dialysis since inclusion of the end-stage renal disease (ESRD) benefit into payment policy in 1973. In the ensuing decades, bundled payments have been introduced for dialysis and quality programs have been adopted for both ESRD and nondialysis chronic kidney disease care. In this installment of the Core Curriculum in Nephrology, we review the key laws and regulations affecting kidney care in the United States, the Medicare ESRD program, quality assessment and pay-for-performance programs including the ESRD Quality Incentive Program, incentives and disincentives for specific kidney failure care modalities, and recent landmark initiatives to promote more coordinated kidney care across the spectrum of kidney disease. Additional discussion covers policies guiding the care of undocumented immigrants and provision of hospice and palliative care to people with kidney failure. Last, we discuss how the kidney community can activate to advocate effectively to promote better kidney care in the United States.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  End-stage renal disease (ESRD); Medicare; advocacy; coordinated care; dialysis; health care policy; kidney failure; palliative care; pay-for-performance; payment models; quality metrics; reimbursement mechanisms; review; transplantation

Mesh:

Year:  2020        PMID: 32771281     DOI: 10.1053/j.ajkd.2020.03.028

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Value-Based Care in Nephrology: The Kidney Care Choices Model and Other Reforms.

Authors:  Gaurav Jain; Daniel E Weiner
Journal:  Kidney360       Date:  2021-08-16

2.  Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.

Authors:  Julie M Paik; Min Zhuo; Cassandra York; Theodore Tsacogianis; Seoyoung C Kim; Rishi J Desai
Journal:  Am J Nephrol       Date:  2021-11-23       Impact factor: 3.754

3.  Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program.

Authors:  Natalie C Ernecoff; Alexandra E Bursic; Erica M Motter; Keith Lagnese; Robert Taylor; Jane O Schell
Journal:  J Am Soc Nephrol       Date:  2022-07-12       Impact factor: 14.978

4.  Association of Public Reporting of Medicare Dialysis Facility Quality Ratings With Access to Kidney Transplantation.

Authors:  Joel T Adler; Lingwei Xiang; Joel S Weissman; James R Rodrigue; Rachel E Patzer; Sushrut S Waikar; Thomas C Tsai
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  The Role of Dialysis Organizations in Promoting and Facilitating Access to Nondialytic Treatment Options.

Authors:  Catherine R Butler; Suzanne Watnick
Journal:  Kidney Med       Date:  2022-05-13

6.  Dialysis and Total Health Care Costs in the United States and Worldwide: The Financial Impact of a Single-Payer Dominant System in the US.

Authors:  Benjamin M Pockros; Daniel J Finch; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2021-08-06       Impact factor: 14.978

7.  Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives.

Authors:  Keren Ladin; Isabel Neckermann; Noah D'Arcangelo; Susan Koch-Weser; John B Wong; Elisa J Gordon; Ana Rossi; Dena Rifkin; Tamara Isakova; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2021-04-07       Impact factor: 14.978

8.  Structural Inequities and Barriers to Accessing Kidney Healthcare Services in the United States: A Focus on Uninsured and Undocumented Children and Young Adults.

Authors:  Franca M Iorember; Oluwatoyin F Bamgbola
Journal:  Front Pediatr       Date:  2022-04-05       Impact factor: 3.418

Review 9.  Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.

Authors:  Janet B McGill; Hermann Haller; Prabir Roy-Chaudhury; Andrea Cherrington; Takashi Wada; Christoph Wanner; Linong Ji; Peter Rossing
Journal:  BMJ Open Diabetes Res Care       Date:  2022-07

10.  Economic evaluation of expanded hemodialysis with the Theranova 400 dialyzer: A post hoc evaluation of a randomized clinical trial in the United States.

Authors:  Michael J Blackowicz; Luke Falzon; Werner Beck; Ha Tran; Daniel E Weiner
Journal:  Hemodial Int       Date:  2022-04-19       Impact factor: 1.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.